Cargando…

Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care

Detalles Bibliográficos
Autores principales: Thomas, W., White, D., Cox-Morton, S., MacDonald, S., Besser, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415167/
https://www.ncbi.nlm.nih.gov/pubmed/32795720
http://dx.doi.org/10.1016/j.thromres.2020.08.010
_version_ 1783569116505833472
author Thomas, W.
White, D.
Cox-Morton, S.
MacDonald, S.
Besser, M.
author_facet Thomas, W.
White, D.
Cox-Morton, S.
MacDonald, S.
Besser, M.
author_sort Thomas, W.
collection PubMed
description
format Online
Article
Text
id pubmed-7415167
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74151672020-08-10 Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care Thomas, W. White, D. Cox-Morton, S. MacDonald, S. Besser, M. Thromb Res Letter to the Editors-in-Chief Elsevier Ltd. 2020-11 2020-08-09 /pmc/articles/PMC7415167/ /pubmed/32795720 http://dx.doi.org/10.1016/j.thromres.2020.08.010 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editors-in-Chief
Thomas, W.
White, D.
Cox-Morton, S.
MacDonald, S.
Besser, M.
Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
title Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
title_full Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
title_fullStr Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
title_full_unstemmed Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
title_short Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
title_sort heparin failure and covid-19: should we explore other anticoagulants? an observational report regarding in-vitro recovery of anticoagulant action in covid-19 patients in intensive care
topic Letter to the Editors-in-Chief
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415167/
https://www.ncbi.nlm.nih.gov/pubmed/32795720
http://dx.doi.org/10.1016/j.thromres.2020.08.010
work_keys_str_mv AT thomasw heparinfailureandcovid19shouldweexploreotheranticoagulantsanobservationalreportregardinginvitrorecoveryofanticoagulantactionincovid19patientsinintensivecare
AT whited heparinfailureandcovid19shouldweexploreotheranticoagulantsanobservationalreportregardinginvitrorecoveryofanticoagulantactionincovid19patientsinintensivecare
AT coxmortons heparinfailureandcovid19shouldweexploreotheranticoagulantsanobservationalreportregardinginvitrorecoveryofanticoagulantactionincovid19patientsinintensivecare
AT macdonalds heparinfailureandcovid19shouldweexploreotheranticoagulantsanobservationalreportregardinginvitrorecoveryofanticoagulantactionincovid19patientsinintensivecare
AT besserm heparinfailureandcovid19shouldweexploreotheranticoagulantsanobservationalreportregardinginvitrorecoveryofanticoagulantactionincovid19patientsinintensivecare